Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 14 | 2022 | 239 | 6.170 |
Why?
|
| Thrombosis | 6 | 2022 | 198 | 2.440 |
Why?
|
| Platelet Activation | 5 | 2021 | 116 | 1.900 |
Why?
|
| Influenza, Human | 2 | 2021 | 195 | 1.320 |
Why?
|
| Hemostasis | 4 | 2020 | 35 | 1.210 |
Why?
|
| Megakaryocytes | 4 | 2022 | 25 | 1.080 |
Why?
|
| Receptor, Adenosine A2B | 7 | 2014 | 10 | 1.060 |
Why?
|
| Adaptive Immunity | 2 | 2022 | 86 | 0.990 |
Why?
|
| Atherosclerosis | 5 | 2014 | 149 | 0.870 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 75 | 0.820 |
Why?
|
| Plague | 1 | 2020 | 25 | 0.810 |
Why?
|
| Yersinia pestis | 1 | 2020 | 34 | 0.800 |
Why?
|
| Virion | 1 | 2020 | 113 | 0.750 |
Why?
|
| Betacoronavirus | 2 | 2020 | 151 | 0.740 |
Why?
|
| Immunity, Innate | 2 | 2022 | 699 | 0.710 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 174 | 0.690 |
Why?
|
| DNA Viruses | 1 | 2018 | 17 | 0.690 |
Why?
|
| Herpesviridae | 1 | 2018 | 15 | 0.680 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 186 | 0.680 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2019 | 95 | 0.660 |
Why?
|
| Influenza A virus | 1 | 2019 | 123 | 0.660 |
Why?
|
| Pandemics | 2 | 2020 | 445 | 0.630 |
Why?
|
| Toll-Like Receptors | 2 | 2020 | 414 | 0.630 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 177 | 0.630 |
Why?
|
| RNA, Viral | 1 | 2018 | 269 | 0.610 |
Why?
|
| Apoptosis | 1 | 2021 | 979 | 0.570 |
Why?
|
| Adenosine | 2 | 2012 | 70 | 0.560 |
Why?
|
| Coxsackievirus Infections | 1 | 2015 | 12 | 0.550 |
Why?
|
| Enterovirus B, Human | 1 | 2015 | 18 | 0.550 |
Why?
|
| Membrane Glycoproteins | 2 | 2019 | 587 | 0.550 |
Why?
|
| MicroRNAs | 2 | 2020 | 646 | 0.550 |
Why?
|
| Myocarditis | 1 | 2015 | 28 | 0.530 |
Why?
|
| Cardiovirus Infections | 1 | 2014 | 11 | 0.520 |
Why?
|
| Encephalomyocarditis virus | 1 | 2014 | 13 | 0.520 |
Why?
|
| Inflammation | 10 | 2022 | 978 | 0.480 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2012 | 10 | 0.470 |
Why?
|
| Animals | 19 | 2022 | 17697 | 0.460 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 52 | 0.440 |
Why?
|
| Humans | 21 | 2022 | 49598 | 0.420 |
Why?
|
| Mice, Knockout | 10 | 2019 | 1871 | 0.420 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 723 | 0.330 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1781 | 0.290 |
Why?
|
| Neutrophils | 2 | 2019 | 332 | 0.260 |
Why?
|
| Blotting, Western | 3 | 2021 | 534 | 0.250 |
Why?
|
| Male | 9 | 2021 | 23121 | 0.240 |
Why?
|
| Female | 9 | 2021 | 26314 | 0.220 |
Why?
|
| Risk Factors | 3 | 2017 | 4246 | 0.220 |
Why?
|
| A549 Cells | 1 | 2021 | 36 | 0.220 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 140 | 0.210 |
Why?
|
| Hibernation | 1 | 2020 | 12 | 0.200 |
Why?
|
| Ursidae | 1 | 2020 | 12 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 552 | 0.200 |
Why?
|
| Mice | 11 | 2016 | 9076 | 0.190 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 53 | 0.190 |
Why?
|
| Endocytosis | 1 | 2020 | 151 | 0.180 |
Why?
|
| Blood Vessels | 2 | 2012 | 55 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 224 | 0.180 |
Why?
|
| Extracellular Traps | 1 | 2019 | 30 | 0.180 |
Why?
|
| Complement C3 | 1 | 2019 | 61 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 148 | 0.170 |
Why?
|
| Collagen | 2 | 2016 | 115 | 0.170 |
Why?
|
| Mean Platelet Volume | 1 | 2017 | 5 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 2854 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 684 | 0.160 |
Why?
|
| Dietary Fats | 3 | 2014 | 205 | 0.160 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2016 | 3 | 0.150 |
Why?
|
| Forecasting | 1 | 2017 | 193 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 100 | 0.150 |
Why?
|
| Thrombophilia | 1 | 2016 | 15 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 499 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 204 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 145 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2017 | 160 | 0.140 |
Why?
|
| Adult | 3 | 2021 | 13325 | 0.140 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2012 | 23 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 668 | 0.140 |
Why?
|
| Obesity | 2 | 2014 | 1125 | 0.140 |
Why?
|
| Hypertension | 1 | 2020 | 542 | 0.140 |
Why?
|
| Cell Degranulation | 1 | 2014 | 20 | 0.130 |
Why?
|
| Platelet Count | 1 | 2014 | 34 | 0.130 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 20 | 0.130 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 108 | 0.130 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 86 | 0.130 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 12 | 0.130 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 201 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 128 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 162 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 249 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2017 | 402 | 0.120 |
Why?
|
| Foam Cells | 1 | 2012 | 4 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2012 | 2681 | 0.120 |
Why?
|
| Middle Aged | 3 | 2019 | 13448 | 0.120 |
Why?
|
| Aged | 2 | 2019 | 10871 | 0.120 |
Why?
|
| Neoplasms | 1 | 2022 | 1058 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 248 | 0.110 |
Why?
|
| Sex Factors | 1 | 2015 | 851 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2012 | 51 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1042 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 79 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1390 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 40 | 0.110 |
Why?
|
| Macrophages | 2 | 2014 | 913 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 1250 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 45 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2014 | 373 | 0.100 |
Why?
|
| Biomarkers | 1 | 2015 | 1002 | 0.100 |
Why?
|
| Homeostasis | 1 | 2012 | 307 | 0.100 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 53 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4222 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 821 | 0.090 |
Why?
|
| Glucose | 1 | 2012 | 371 | 0.090 |
Why?
|
| Massachusetts | 1 | 2015 | 2017 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2020 | 349 | 0.090 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2008 | 10 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 63 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 33 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1499 | 0.080 |
Why?
|
| Liver | 1 | 2011 | 709 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 835 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2006 | 215 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 604 | 0.070 |
Why?
|
| Platelet Adhesiveness | 2 | 2016 | 13 | 0.070 |
Why?
|
| Nanomedicine | 1 | 2022 | 27 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 110 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1114 | 0.050 |
Why?
|
| Adenosine A2 Receptor Agonists | 2 | 2012 | 7 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 95 | 0.050 |
Why?
|
| Antithrombin III | 1 | 2020 | 16 | 0.050 |
Why?
|
| Angiotensins | 1 | 2020 | 4 | 0.050 |
Why?
|
| Seasons | 1 | 2020 | 121 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 620 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 131 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2020 | 169 | 0.050 |
Why?
|
| Rats | 2 | 2016 | 1679 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 354 | 0.040 |
Why?
|
| Inpatients | 1 | 2020 | 257 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 118 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1247 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 220 | 0.040 |
Why?
|
| Integrin alpha2beta1 | 1 | 2016 | 1 | 0.040 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2016 | 5 | 0.040 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 11 | 0.040 |
Why?
|
| Platelet Factor 4 | 1 | 2016 | 9 | 0.040 |
Why?
|
| Bacteroidaceae Infections | 1 | 2014 | 7 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2016 | 325 | 0.030 |
Why?
|
| Porphyromonas gingivalis | 1 | 2014 | 22 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 47 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 74 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 117 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 95 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 456 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2012 | 20 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 184 | 0.030 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2012 | 5 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 190 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 235 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 54 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 428 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 790 | 0.030 |
Why?
|
| Cholesterol | 1 | 2012 | 262 | 0.030 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2010 | 4 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2010 | 130 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2010 | 73 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1920 | 0.020 |
Why?
|
| NADPH Oxidase 4 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 658 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 589 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 186 | 0.020 |
Why?
|
| Aorta | 1 | 2008 | 88 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 496 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2006 | 2 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 47 | 0.020 |
Why?
|
| E-Selectin | 1 | 2006 | 23 | 0.020 |
Why?
|
| P-Selectin | 1 | 2006 | 36 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 623 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 993 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 364 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 215 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2017 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 884 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 3127 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 816 | 0.010 |
Why?
|